Amyloid plaques in TBI
Incidental finding or precursor for what is to come?
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Over the past decade, the rate of traumatic brain injury (TBI)-related emergency department visits has increased by 70% and was estimated in 2010 at a staggering 2.5 million visits. This number is an underestimate as it does not include individuals who did not seek/receive medical care, are part of the US military service, or cared for by the Department of Veterans Affairs. One estimate states that 3 to 5 million Americans live with a TBI-related disability.1 Of particular concern, recent data suggest an increased risk of dementia after TBI. However, it remains unclear whether there is indeed a specific link between the occurrence of Alzheimer disease (AD) later in life and a history of TBI. The suspicion of a causal relationship between TBI and AD mostly stems from the sudden emergence of the toxic β-amyloid (Aβ) protein observed in the brains of even young patients. This finding has been puzzling, as Aβ is a hallmark of AD, a late-life dementia. Whether the primarily axonal increase of Aβ is simply an epiphenomenon of TBI pathology or actually a precursor to the distinctively different extraneuronal fibrillar Aβ plaques seen in AD remains elusive.
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the editorial.
See page 821
- © 2016 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.